CASICASI PharmaceuticalsCASI info
$6.85info1.33%24h
Global rank21676
Market cap$91.25M
Change 7d7.20%
YTD Performance-2.84%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    CASI Pharmaceuticals (CASI) Stock Overview

    CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Republic of China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's other hematology/oncology assets in pipeline include CNCT 19, an autologous CD19 CAR-T investigative product; BI-1206, novel anti-Fc?RIIB antibody, for the treatment of solid tumors and relapsed/refractory non-hodgkin lymphoma; CB-5339, a novel VCP/p97 inhibitor that focuses on valosin-containing protein (VCP)/p97 as a novel target in protein homeostasis, DNA damage response, and other cellular stress pathways for therapeutic use in the treatment of patients with various malignancies; and CID-103, a human IgG1 anti-CD38 monoclonal antibody. The company has licensing agreements with Juventas Biotechnology (Tianjin) Co., Ltd.; BioInvent International AB; Black Belt Therapeutics Limited; Cleave Therapeutics, Inc.; and Acrotech Biopharma L.L.C. to develop and commercialize its commercial product EVOMELA. It also has distribution agreements with China Resources Pharmaceutical Commercial Group International Trading Co., Ltd; Pharmathen Global BV; and Riemser Pharma GmbH. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Beijing, the People's Republic of China.

    CASI Stock Information

    Symbol
    CASI
    Address
    1701-1702, China Central Office Tower 1Beijing, 100025China
    Founded
    -
    Trading hours
    -
    Website
    https://www.casipharmaceuticals.com
    Country
    πŸ‡¨πŸ‡³ China
    Phone Number
    86 10 6508 6063

    CASI Pharmaceuticals (CASI) Price Chart

    -
    Value:-

    CASI Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $6.85
    N/A
    Market Cap
    $91.25M
    N/A
    Shares Outstanding
    13.32M
    N/A
    Employees
    224.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org